It is possible that SGLT2 inhibitors trigger euglycemic diabetic ketoacidosis in some patients. Possible mechanism of euglycemic DKA induced by SGLT2 inhibitors is illustrated.Wataru OgawaDivision of Diabetes and EndocrinologyKazuhiko SakaguchiDivision of Diabetes and EndocrinologyJournal of Diabetes ...